Dynavax Technologies | Devedores Comerciais

Trade Debtors Alterar Data
AbbVie USD 11.95B 537M 2024-03
Adma Biologics USD 49.62M 22.2M 2024-03
Amgen USD 6.78B 492M 2024-03
AstraZeneca USD 12B 65M 2023-09
Biogen USD 2B 100.3M 2024-03
BioMarin Pharmaceutical USD 637.16M 3.46M 2024-03
Bristol-Myers Squibb USD 14.06B 1.59B 2024-03
Dynavax Technologies USD 46.15M 1.62M 2024-03
Gilead Sciences USD 4.67B 9M 2024-03
Merck USD 11.37B 119M 2024-03
Neurocrine Biosciences USD 450.7M 32.9M 2024-03
Novartis USD 8.25B 718M 2024-03
Pfizer USD 15.22B 219M 2024-03
Regeneron Pharmaceuticals USD 5.22B 445.1M 2024-03
Roche Holding CHF 11.36B 560M 2023-06
Sarepta Therapeutics USD 419.38M 65.12M 2024-03
TG Therapeutics USD 64.98M 25.66M 2024-03
Vertex Pharmaceuticals USD 1.79B 254.5M 2024-03



Dynavax Technologies Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.